Industry: Pharmaceutical industry
Customer brand: CanSino
Brand business: to provide solutions for the prevention of infectious diseases and infectious diseases in the world as its mission, specializing in the research and development, production and commercialization of high-quality human vaccines, is a leading high-tech biological products enterprise in China.
✦✦
01
Customer Introduction
CanSino Bio AG (Abbreviation: CanSino Bio, ticker symbol 6185. HK, 688185.SH) is a national high-tech enterprise founded by the senior management team of multinational pharmaceutical companies. In March 2019, CanSino Bio was listed on the H shares of the main board of the Hong Kong Stock Exchange; On August 13, 2020, CanSino Bio officially landed on the Science and Technology Innovation Board, becoming the first "A+H" vaccine stock since the opening of the Science and Technology Innovation Board.
The R&D team of CanSino Bio brings together a number of well-known scientists and senior experts in the vaccine industry who lead the innovation of international vaccine research and development, establishes five core technology platforms based on viral vector technology, synthetic vaccine technology, protein structure design and recombinant technology, mRNA vaccine technology and preparation and drug delivery technology, has a number of vaccine core intellectual property rights and proprietary technologies, and establishes 17 innovative vaccine product research and development pipelines for 12 disease fields, covering novel coronavirus pneumonia, Ebola virus disease and tuberculosis Prevention of a series of diseases such as meningitis, diphtheria, and shingles.
✦✦
02
Selective thinking
As an innovative vaccine pharmaceutical company, CanSino Bio is facing a common problem in this industry, that is, how to quickly commercialize the R&D products after the R&D output results and increase the market share. The transformation from Biotech to the all-round Biopharma company is inseparable from the continuous optimization and improvement of the company's marketing capabilities. The rapid development of enterprises, the fine division of labor of functions, and the continuous expansion of business put forward higher requirements for the way and precision of management. In order to adapt more quickly to the changes in the future environment, improving the management efficiency of the financial and marketing business and strengthening the commercialization ability of the enterprise has become the only way for CanSino. CanSino Bio needs a mature financial digital management system to inject internal driving force into enterprise management.
As a supplier that has served many large and medium-sized pharmaceutical companies and focused on the construction of financial digital systems, Yunjian Industry Has been favored by CanSino Biologics. The cloud-based financial integration financial sharing platform helps CanSino to simplify management, provides canSino with an intelligent mobile software system, helps realize the integration of enterprise industry and finance, and solves a series of new challenges faced by enterprise development:
As an "A+H" double-listed company, how to improve the efficiency of compliance management and reduce corporate compliance risks?
Sales scale grows rapidly, cost input comes first, performance output comes later, how to carry out dynamic budget control, so as to achieve cost reduction and efficiency increase?
While improving management, how to improve the efficiency of business departments and financial departments synchronously, and invest time and energy in the main business?
✦✦
03
Achieve results
In order to meet the urgent needs of customers, the project team of Yunjian Industry Finance conducted in-depth business research on the above problems, and while sorting out and optimizing the relevant processes with the project team of CanSino Biologics, it was finally determined that the system implementation revolved around the six scenarios of "travel expenses, daily expenses, hospitality expenses, academic conference expenses, Non-PO payment management, and cost sharing and withholding management", realizing the landing of expense budgeting, compliance and accounting management, and realizing the realization of CanSino Bio:
Closed-loop management of marketing activities
From the most front-end activity application, to the follow-up activity execution record, activity reimbursement, to achieve the whole process of closed-loop management, business information and financial information effective correlation, multi-dimensional accounting of cost investment, easy to follow-up business investment analysis, to optimize the company's expense management, investment strategy to provide data basis.
Intelligent and efficient compliance management
Through the automatic verification and re-check function of the system invoice, the logical rationality and attachment integrity check between bills, expenses and business information are realized, the joint inspection and verification of the business data and financial data obtained by the docking consumption platform, combined with the multi-type compliance inspection rules configured in the system, multi-type and multi-mode intelligent compliance inspection is realized, which greatly improves the compliance governance level of CanSino Biologics.
Timely and granular budget management
By sorting out and landing a series of company centralized procurement management processes, the budget control link is moved forward, "advance control" is realized, and the system supports multi-dimensional synchronous management of the budget, which can realize the budget management mode of organizational structure + project matrix; Combined with the private + public cost control process, flexible and refined to achieve comprehensive budget management of expenses.
Business + financial efficiency improvement
Yunjian Yecai optimized the compliance management capabilities related to employee expense reimbursement for CanSino Bio, including the realization of invoice verification, reimbursement weight prevention, differential standard control and other functions, reducing the current large number of manual operations that rely on manual identification, through docking machine wine, train, meal, car and other platforms, to achieve convenient consumption of employees, the public settlement without advance, invoicing, reduce the overall reimbursement workload, improve business reimbursement efficiency, help business personnel focus more on business development work.
Through the docking of SAP and the capital system, the "one-stop" experience from accounting review to automatic payment to financial accounting is realized. Yunjian Industry Finance helps CanSino Bio to build an efficient financial digital management system, which not only improves the efficiency of cost control, payment and accounting processes, but also provides a systematic guarantee for enterprises to separately account for R&D expenses and production and operation expenses in accordance with the requirements of the national financial accounting system, and to accurately and reasonably account for expenses.
✦✦
04
Testimonials
Yunjian Industry Finance always takes customer value as the center and cuts into the business scenarios with industry characteristics, helping pharmaceutical companies to create an efficient, controllable and visualized financial digital management system, improving the efficiency of enterprise operation and management, and thus helping enterprises create greater social value. Since the launch of the first phase of the CanSino project in February 2021, with the continuous improvement of customer management needs, up to now, Yunjian is carrying out the 9th phase of optimization projects for CanSino, providing the company with continuous quality services and best application practices. Along the way, Yunjian has also continued to gain high recognition from customers, and customers have sent thank-you letters many times:
Customer Thank You Letter One
Customer thank you letter two